Flibanserin for hypoactive sexual desire disorder in premenopausal women

    loading  Checking for direct PDF access through Ovid

Abstract

Flibanserin is a mixed 5-HT1A agonist and 5-HT2A antagonist for treatment of premenopausal women with hypoactive sexual desire disorder. It is the first FDA-approved treatment for this disorder and can improve the number of satisfying sexual events. The drug has been associated with hypotension and syncope.

Related Topics

    loading  Loading Related Articles